NO20071458L - Nanopartikkel og fremgangsmate for fremstilling av denne - Google Patents

Nanopartikkel og fremgangsmate for fremstilling av denne

Info

Publication number
NO20071458L
NO20071458L NO20071458A NO20071458A NO20071458L NO 20071458 L NO20071458 L NO 20071458L NO 20071458 A NO20071458 A NO 20071458A NO 20071458 A NO20071458 A NO 20071458A NO 20071458 L NO20071458 L NO 20071458L
Authority
NO
Norway
Prior art keywords
gelatin
preparation
nanoparticle
maximum
nanoparticles
Prior art date
Application number
NO20071458A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Ahlers
Conrad Coester
Klaus Zwiorek
Jan Zillies
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of NO20071458L publication Critical patent/NO20071458L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
NO20071458A 2004-08-20 2007-03-19 Nanopartikkel og fremgangsmate for fremstilling av denne NO20071458L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004041340A DE102004041340A1 (de) 2004-08-20 2004-08-20 Nanopartikel und Verfahren zu deren Herstellung
PCT/EP2005/008954 WO2006021367A1 (de) 2004-08-20 2005-08-18 Nanopartikel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
NO20071458L true NO20071458L (no) 2007-03-19

Family

ID=35276582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071458A NO20071458L (no) 2004-08-20 2007-03-19 Nanopartikkel og fremgangsmate for fremstilling av denne

Country Status (14)

Country Link
US (1) US20080003292A1 (pt)
EP (1) EP1793810A1 (pt)
JP (1) JP2008510688A (pt)
KR (1) KR20070046850A (pt)
CN (1) CN1988892A (pt)
AU (1) AU2005276675A1 (pt)
BR (1) BRPI0514524A (pt)
CA (1) CA2575407A1 (pt)
DE (1) DE102004041340A1 (pt)
IL (1) IL180954A0 (pt)
MX (1) MX2007001996A (pt)
NO (1) NO20071458L (pt)
NZ (1) NZ551326A (pt)
WO (1) WO2006021367A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070184068A1 (en) 2005-12-14 2007-08-09 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007072982A1 (en) * 2005-12-20 2007-06-28 Fujifilm Corporation Protein nanoparticles and the use of the same
JP2007224012A (ja) * 2006-01-30 2007-09-06 Fujifilm Corp 酵素架橋したタンパク質ナノ粒子
CA2655108C (en) 2006-06-12 2019-05-07 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
JP2008001764A (ja) * 2006-06-21 2008-01-10 Gunma Univ タンパク質からなる粒子状成形体の製造方法及び、該方法により得られたタンパク質からなる粒子状成形体
JP5275561B2 (ja) * 2006-10-30 2013-08-28 富士フイルム株式会社 水分散可能なナノ粒子
DE602007002784D1 (de) * 2007-03-16 2009-11-26 Univ Nat Chi Nan Bioabbaubares Material mit Nanoporen und elektrischer Leitfähigkeit sowie Herstellungsverfahren dafür
JP2008260705A (ja) * 2007-04-11 2008-10-30 Fujifilm Corp 注射用組成物
JP2008297241A (ja) * 2007-05-31 2008-12-11 Fujifilm Corp ニキビ用皮膚外用剤
DE102007041625A1 (de) * 2007-09-03 2009-03-05 Sinn, Hannsjörg, Dr. Neue Gelatine-Wirkstoff-Konjugate
KR102238108B1 (ko) * 2010-11-10 2021-04-12 인리젠 장기 확대를 위한 주사가능 제제
EP2540287A1 (en) * 2011-07-01 2013-01-02 FutureChemistry Continuous flow production of gelatin nanoparticles
DE102011052396A1 (de) * 2011-08-04 2013-02-07 Gelita Ag Verfahren zur Herstellung einer stabilen Dispersion von Nanopartikeln, hergestellte Dispersion und deren Verwendung
US20190002530A1 (en) * 2015-12-25 2019-01-03 Konica Minolta, Inc. Gelatin particles, method for producing gelatin particles, gelatin particle-containing cell, and method for producing gelatin particle-containing cell
CN108495709B (zh) 2016-01-25 2021-09-03 三得利控股株式会社 含有功能性物质的胶囊及其制造方法
CN107376008B (zh) 2017-07-21 2019-10-22 深圳华诺生物科技有限公司 一种无机纳米颗粒-明胶核壳结构复合材料颗粒的制备方法
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
EP3954399B1 (en) * 2020-04-09 2023-11-15 Plmicromed Co., Ltd. Microbeads for embolization and composition for treating proliferative diseases
KR102386631B1 (ko) * 2020-04-09 2022-04-15 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
KR102645182B1 (ko) * 2021-08-23 2024-03-07 전남대학교산학협력단 젤라틴 가교입자의 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US5932245A (en) * 1991-12-05 1999-08-03 Alfatec Pharma Gmbh Gelatin or collagen hydrolysate containing drug formulation that provides for immediate release of nanoparticle drug compounds
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE19838189A1 (de) * 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
AU773279B2 (en) * 1999-04-08 2004-05-20 Johns Hopkins University, The Antigen-specific induction of peripheral immune tolerance
DE60334924D1 (de) * 2002-09-11 2010-12-23 Elan Pharma Int Ltd Anoteilchengrösse
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung

Also Published As

Publication number Publication date
AU2005276675A1 (en) 2006-03-02
BRPI0514524A (pt) 2008-06-10
JP2008510688A (ja) 2008-04-10
EP1793810A1 (de) 2007-06-13
KR20070046850A (ko) 2007-05-03
US20080003292A1 (en) 2008-01-03
DE102004041340A1 (de) 2006-02-23
NZ551326A (en) 2010-04-30
CA2575407A1 (en) 2006-03-02
MX2007001996A (es) 2007-05-10
IL180954A0 (en) 2007-07-04
CN1988892A (zh) 2007-06-27
WO2006021367A1 (de) 2006-03-02

Similar Documents

Publication Publication Date Title
NO20071458L (no) Nanopartikkel og fremgangsmate for fremstilling av denne
Peng et al. Simple aqueous solution route to luminescent carbogenic dots from carbohydrates
NO20071974L (no) Blodplate-avledet vekstfaktor sammensetning og fremgangsmater for anvendelse derav
BR0305916A (pt) Dispersão, composição cosmética ou farmacêutica e processo para tratamento cosmético
TR200200649T2 (tr) Farmasötik özelliklere sahip olan yeni aminodikarboksilik asit türevleri
DE602005015704D1 (de) Flüssige dispersionspolymerzusammensetzungen, ihre herstellung und ihre verwendung
DE60222007D1 (de) Polymermicellenzusammensetzung mit verbesserter stabilität
WO2008129106A3 (es) Nanopartículas que comprenden una ciclodextrina y una molécula biológicamente activa y sus aplicaciones
CO5540367A2 (es) Composicion de liberacion controlada y metodo para producirla
DE50307767D1 (de) Kosmetische zubereitung
BR0311700A (pt) Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula
Li et al. Carbon dot/poly (methylacrylic acid) nanocomposite hydrogels with high toughness and strong fluorescence
Li et al. Photocontrollable water-soluble polymeric hydrogen sulfide (H2S) donor
WO2011005666A3 (en) Methods for treating hydrocarbon-bearing formations with fluorinated acid compositions
NO20050247L (no) Lavmolekylaert oversulfatert polysakkarid
UA101035C2 (ru) Смягчающая композиция на основе вазелина, глицерина и вазелинового масла
WO2007017901A3 (en) Silver nanoparticle dispersion formulation
Yong et al. The unexplored potential of gas‐responsive polymers in drug delivery: progress, challenges and outlook
Keshavarz et al. The ability of retention, drug release and rheological properties of nanogel bioadhesives based on cellulose derivatives
Shahoon et al. Evaluation of cytotoxicity of hydroxyapatite nanoparticles on L929 fibroblast cells
CN103911680A (zh) 一种复合胶原纤维及其制备方法
ITMI20032498A1 (it) Polisaccaridi antitrombotici a basso peso molecolare e
WO2008102144A3 (en) Aqueous formulations
Wang et al. Effects of Topographic Gradients and Plant Physiological Factors on Leaf Wax n-Alkanes in Quercus buckleyi and Juniperus ashei
Naveed et al. Physical engineering of rhizosphere by plant exudates varies with species, origin and microbial decomposition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application